Latest Breaking News On - Punit dhillon - Page 8 : comparemela.com

Skye Bioscience Inc receives US FDA authorization of Investigational New Drug Application for SBI-100 OE

Skye Bioscience Inc receives US FDA authorization of Investigational New Drug Application for SBI-100 OE
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Skye biosciencePunit dhillonTu diepSkye bioscience incDrug administrationInvestigational new drug

Skye Bioscience (SKYE) Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE

Skye Bioscience (SKYE) Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPunit dhillonTu diepSkye bioscience incDrug administrationInvestigational new drugChief development officer

Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE

Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSkye biosciencePunit dhillonTu diepExchange commissionSkye bioscience incCalifornia newsfile corpDrug administrationWall streetInvestigational new drugChief development officerRisk factors

Skye Bioscience Doses First Cohort of Participants in Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion

Skye Bioscience Doses First Cohort of Participants in Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesUnited kingdomSouth australiaSkye biosciencePunit dhillonExchange commissionDrug administration onSkye bioscience incCalifornia newsfile corpGlaucoma research foundationClinical researchWall streetInvestigational new drugDrug administrationBritish journal

Skye Bioscience Inc says dosing completed of SBI-100 Ophthalmic Emulsion in first cohort of the single ascending dose part of its Phase 1 study

Skye Bioscience Inc (OTCQB:SKYE) said it has completed dosing of SBI-100 Ophthalmic Emulsion (OE) in the first cohort of healthy participants in the single.

United statesUnited kingdomSouth australiaPunit dhillonSkye bioscience incGlaucoma research foundationClinical researchDrug administrationInvestigational new drugBritish journal